李任, 祝淑钗, 沈文斌, 邱嵘, 王玉祥, 李娟. 170例食管癌患者放射治疗疗效分析[J]. 中国肿瘤临床, 2007, 34(19): 1112-1115,1116.
引用本文: 李任, 祝淑钗, 沈文斌, 邱嵘, 王玉祥, 李娟. 170例食管癌患者放射治疗疗效分析[J]. 中国肿瘤临床, 2007, 34(19): 1112-1115,1116.
Li Ren, Zhu Shuchai, Shen Wenbin, Qiu Rong, Wang Yuxiang, Li Juan. Effects of Different Radiotherapy Techniques on 170 Cases with Esophageal Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 34(19): 1112-1115,1116.
Citation: Li Ren, Zhu Shuchai, Shen Wenbin, Qiu Rong, Wang Yuxiang, Li Juan. Effects of Different Radiotherapy Techniques on 170 Cases with Esophageal Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 34(19): 1112-1115,1116.

170例食管癌患者放射治疗疗效分析

Effects of Different Radiotherapy Techniques on 170 Cases with Esophageal Carcinoma

  • 摘要: 目的 :回顾性分析食管癌三种不同放射治疗方式的疗效和放疗毒副反应,为中晚期食管癌根治性放疗提供参考方案。 方法 :对170例符合入组条件的食管癌三维适形放疗(3D-CRT)、后程加速超分割放疗(LCAF)及常规分割放疗(CF)的患者的生存率采用Kaplan Meier法进行生存分析,并用Logrank法进行显著性检验;组间比较采用χ2检验;并采用Cox逐步回归模型进行多因素分析,评估独立预后因素。 结果 :3D-CRT组1、2、3年局控率及生存率均较CF组高,且差异有显著性(P<0.05)。LCAF组1、2、3年局控率及生存率均较CF组高,但差异无显著性(P>0.05)。3D-CRT组放射性食管炎发生率与CF组相似,放射性肺炎发生率低于后者,但无统计学意义(P=0.260)。LCAF组放射性食管炎及放射性肺炎发生率均高于CF组,但差异均无显著性(P>0.05)。 结论 :食管癌三维适形放疗及后程加速超分割放疗的局控率、近期生存率优于常规放疗,但三维适形放疗优越性更明显且其毒副反应更轻。

     

    Abstract: Objective :The effects of 3-dimensional conformal radiotherapy (3D-CRT), late courseaccelerated hyperfraction radiotherapy (LCAF) and conventional radiotherapy (CF) on esophageal carci-noma were retrospectively reviewed. Methods :Data from 170 patients with esophageal carcinoma treat-ed between October 2000 and March 2003 were collected and the patients were divided into threegroups according to the radiotherapy received. Kaplan-Meier survival analysis, Log-rank test and χ2 test were used to evaluate the effects and side effects of the different radiotherapies. The factors relatedto the prognosis were analyzed by COX multivariate analysis. Results :The 1-, 2-, and 3-year localcontrol rates and survival rates in the 3D-CRT group were 88.1%, 79.0%, 74.4% and 76.9%, 53.9%,44.9% compared to 79.8%, 57.5%, 37.4% and 72.0%, 36.0%, 24.6% in the CF group (P<0.05). Therewas no significant difference in the 1-, 2-, and 3-year local control rates and survival rates betweenthe LCAF group and the CF group (P>0.05). In the 3D-CRT group, the incidence of radiation-inducedesophagitis was similar to that seen in the CF group (24.6% vs. 24.0%), but the rate of radiation-in-duced pneumonitis was lower than that observed in the CF group (12.3% vs. 20.0%, P=0.260). Therewas no significant difference in the incidence rate of radiation-induced esophagitis and pneumonitis be-tween the LCAF group and the CF group (P>0.05). Conclusion :3D-CRT and LCAF have superior ef-fects on patients with esophageal carcinoma than those of CF. And with fewer side effects, 3D-CRT is asuperior option in the radiotherapy of esophageal Carcinoma.

     

/

返回文章
返回